Literature DB >> 24009177

An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation.

Rommel Chacón-Salinas1, Limo Chen, Alma D Chávez-Blanco, Alberto Y Limón-Flores, Ying Ma, Stephen E Ullrich.   

Abstract

The UVB (290-320 nm) radiation in sunlight is responsible for inducing skin cancer. Exposure to UV radiation is also immunosuppressive, and the systemic immune suppression induced by UV is a well-recognized risk factor for cancer induction. As UVB radiation is absorbed within the upper layers of the skin, indirect mechanisms must play a role in activating systemic immune suppression. One prominent example is mast cell migration, which from the skin to the draining LN is an essential step in the cascade of events leading to immune suppression. What triggers mast cell migration is not entirely clear. Here, we tested the hypothesis that PAF, a lipid mediator of inflammation produced by the skin in response to UV exposure, is involved. Mast cell-deficient mice (Kit(W-sh/W-sh)) are resistant to the suppressive effect of UV radiation, and reconstituting mast cell-deficient mice with normal bone marrow-derived mast cells restores susceptibility to immunosuppression. However, when mast cells from PAFR-/- mice were used, the reconstituted mice were not susceptible to the suppressive effects of UV. Furthermore, PAFR-/- mice showed impaired UV-induced mast cell migration when compared with WT mice. Finally, injecting PAF into WT mice mimicked the effect of UV irradiation and induced mast cell migration but not in PAFR-/- mice. Our findings indicate that PAFR binding induces mast cells to migrate from the skin to the LNs, where they mediate immune suppression.

Entities:  

Keywords:  UV radiation; cell trafficking; immune suppression; inflammatory mediators

Mesh:

Substances:

Year:  2013        PMID: 24009177      PMCID: PMC3868193          DOI: 10.1189/jlb.0811409

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  61 in total

1.  Identification of platelet-activating factor acetylhydrolase II in human skin.

Authors:  Mariangela Marques; Yong Pei; Michael D Southall; John M Johnston; Hiroyuki Arai; Junken Aoki; Takao Inoue; Holger Seltmann; Christos C Zouboulis; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2002-10       Impact factor: 8.551

2.  Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans.

Authors:  T Yoshikawa; V Rae; W Bruins-Slot; J W Van den Berg; J R Taylor; J W Streilein
Journal:  J Invest Dermatol       Date:  1990-11       Impact factor: 8.551

3.  Antigenicity of murine skin tumors induced by ultraviolet light.

Authors:  M L Kripke
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

Review 4.  Platelet-activating factor receptor: gene expression and signal transduction.

Authors:  T Izumi; T Shimizu
Journal:  Biochim Biophys Acta       Date:  1995-12-07

5.  Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma.

Authors:  H U Simon; P W Tsao; K A Siminovitch; G B Mills; K Blaser
Journal:  J Immunol       Date:  1994-07-01       Impact factor: 5.422

6.  Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor.

Authors:  A Marilise Marrache; Fernand Gobeil; Sylvie G Bernier; Jana Stankova; Marek Rola-Pleszczynski; Sanaa Choufani; Ghassan Bkaily; Annie Bourdeau; Martin G Sirois; Alejandro Vazquez-Tello; Li Fan; Jean-Sébastien Joyal; Janos G Filep; Daya R Varma; Alfredo Ribeiro-Da-Silva; Sylvain Chemtob
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

7.  Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10.

Authors:  J M Rivas; S E Ullrich
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

8.  Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice.

Authors:  M S Fisher; M L Kripke
Journal:  Science       Date:  1982-06-04       Impact factor: 47.728

9.  Identification of functional platelet-activating factor receptors on human keratinocytes.

Authors:  J B Travers; J C Huff; M Rola-Pleszczynski; E W Gelfand; J G Morelli; R C Murphy
Journal:  J Invest Dermatol       Date:  1995-12       Impact factor: 8.551

10.  Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology.

Authors:  E C De Fabo; F P Noonan
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

View more
  20 in total

Review 1.  UVB-generated Microvesicle Particles: A Novel Pathway by Which a Skin-specific Stimulus Could Exert Systemic Effects.

Authors:  Katherine Fahy; Langni Liu; Christine M Rapp; Christina Borchers; Ji C Bihl; Yanfang Chen; Richard Simman; Jeffrey B Travers
Journal:  Photochem Photobiol       Date:  2017-03-02       Impact factor: 3.421

Review 2.  The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

3.  Chromatin Modifications and Mast Cell Migration in UV-Induced Immunosuppression, an Epigenetic Piece of The Puzzle.

Authors:  Remco van Doorn; Frank de Gruijl
Journal:  J Invest Dermatol       Date:  2015-12       Impact factor: 8.551

4.  Platelet-Activating Factor-Induced Reduction in Contact Hypersensitivity Responses Is Mediated by Mast Cells via Cyclooxygenase-2-Dependent Mechanisms.

Authors:  Jesus A Ocana; Eric Romer; Ravi Sahu; Sven-Christian Pawelzik; Garret A FitzGerald; Mark H Kaplan; Jeffrey B Travers
Journal:  J Immunol       Date:  2018-04-25       Impact factor: 5.422

Review 5.  Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.

Authors:  Elisabetta Damiani; Stephen E Ullrich
Journal:  Prog Lipid Res       Date:  2016-04-09       Impact factor: 16.195

6.  Platelet-Activating Factor Induces Epigenetic Modifications in Human Mast Cells.

Authors:  Elisabetta Damiani; Nahum Puebla-Osorio; Enrique Gorbea; Stephen E Ullrich
Journal:  J Invest Dermatol       Date:  2015-08-28       Impact factor: 8.551

7.  Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin.

Authors:  Ravi P Sahu; Samin Rezania; Jesus A Ocana; Sonia C DaSilva-Arnold; Joshua R Bradish; Justin D Richey; Simon J Warren; Badri Rashid; Jeffrey B Travers; Raymond L Konger
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

8.  Mast Cells in Lung Homeostasis: Beyond Type I Hypersensitivity.

Authors:  Marcia Campillo-Navarro; Alma D Chávez-Blanco; Isabel Wong-Baeza; Jeanet Serafín-López; Raúl Flores-Mejía; Sergio Estrada-Parra; Iris Estrada-García; Rommel Chacón-Salinas
Journal:  Curr Respir Med Rev       Date:  2014-06

9.  Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells.

Authors:  N Puebla-Osorio; E Damiani; L Bover; S E Ullrich
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

10.  Radiation therapy generates platelet-activating factor agonists.

Authors:  Ravi P Sahu; Kathleen A Harrison; Jonathan Weyerbacher; Robert C Murphy; Raymond L Konger; Joy Elizabeth Garrett; Helen Jan Chin-Sinex; Michael Edward Johnston; Joseph R Dynlacht; Marc Mendonca; Kevin McMullen; Gengxin Li; Dan F Spandau; Jeffrey B Travers
Journal:  Oncotarget       Date:  2016-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.